GENE ONLINE|News &
Opinion
Blog

Cell and Gene Therapy
Novartis Books Gyroscope for $1.5 Billion in Pursuit of Gene Therapy for Blindness
2021-12-23
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
FDA Approves Kite’s CAR-T Therapy for Adult Leukemia
2021-10-04
What Does It Take for a Cell & Gene Therapy Program to Go Commercial?
2021-09-30
Takeda’s Allogeneic Stem Cell Therapy Becomes First of Its Kind to Be Approved in Japan
2021-09-28
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
Gilead’s Kite Wins Legal Battle Against BMS, Gets Its $1.2B Fine Overturned
2021-08-27
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
Astellas Makes a $440M+ Pact with Minovia to Develop Mitochondrial Cell Therapies
2021-08-03
BIO Asia 2021 Highlights: Realizing The Promise of Cell and Gene Therapies
2021-08-02
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
Celgene Spinoff Arrives Wall Street with a $138 Million SPAC Deal
2021-07-19
In Quest For Scalability in Cell Therapy Manufacturing, Cellares Partners with Poseida
2021-07-14
Gilead’s CAR-T Drug Outperforms Standard of Care in B-Cell Lymphoma Trial
2021-06-29
1 2 3 4 5 6
LATEST
Early Patient Involvement in Drug Development Linked to Reduced Costs and Faster Timelines
2026-04-15
One in Four U.S. Adults Turns to AI Tools for Health Care Advice
2026-04-15
Policy, Pricing, and Power: Why Europe’s Biotech Future Depends on Openness, Not Overregulation
2026-04-14
Vitiligo: Causes, Life-Changing Impacts, Treatment Challenges, and Breakthrough New Drugs
2026-04-14
Chris Chen Presents Faraday Future AI Robotics Advancements at Harvard Science Center
2026-04-14
General Lance W. Lord to Receive Space Foundation Lifetime Space Achievement Award for Leadership in Military Space Operations
2026-04-14
Ronald Kopas Reports 11.2 Percent Ownership in Delta Resources Following Private Share Acquisition
2026-04-14
Scroll to Top